Page last updated: 2024-10-18

dihydroxyphenylalanine and Neuritis

dihydroxyphenylalanine has been researched along with Neuritis in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Neuritis: A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barber, A1
Bartoszyk, GD1
Greiner, HE1
Mauler, F1
Murray, RD1
Seyfried, CA1
Simon, M1
Gottschlich, R1
Harting, J1
Lues, I1
Satoyashi, E1
Narabayashi, H1
Tsubaki, T1
Mozai, T1
Sobue, I1

Other Studies

2 other studies available for dihydroxyphenylalanine and Neuritis

ArticleYear
Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: Analgesics; Animals; Brain; Carrageenan; Dihydroxyphenylalanine; Diuresis; Electric Stimulation; For

1994
[Round table discussion: topics on neuromuscular disease].
    Naika. Internal medicine, 1971, Volume: 28, Issue:3

    Topics: Abdomen; Dihydroxyphenylalanine; Humans; Myelitis; Myositis; Neuritis; Neuromuscular Diseases; Neuro

1971